These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22223733)

  • 1. Mirtron microRNA-1236 inhibits VEGFR-3 signaling during inflammatory lymphangiogenesis.
    Jones D; Li Y; He Y; Xu Z; Chen H; Min W
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):633-42. PubMed ID: 22223733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
    Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
    Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis.
    Durré T; Morfoisse F; Erpicum C; Ebroin M; Blacher S; García-Caballero M; Deroanne C; Louis T; Balsat C; Van de Velde M; Kaijalainen S; Kridelka F; Engelholm L; Struman I; Alitalo K; Behrendt N; Paupert J; Noel A
    Nat Commun; 2018 Dec; 9(1):5178. PubMed ID: 30518756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular controls of lymphatic VEGFR3 signaling.
    Deng Y; Zhang X; Simons M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
    J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.
    Flister MJ; Wilber A; Hall KL; Iwata C; Miyazono K; Nisato RE; Pepper MS; Zawieja DC; Ran S
    Blood; 2010 Jan; 115(2):418-29. PubMed ID: 19901262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis.
    Jones D; Xu Z; Zhang H; He Y; Kluger MS; Chen H; Min W
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2553-61. PubMed ID: 20864667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
    Syväranta S; Helske S; Lappalainen J; Kupari M; Kovanen PT
    Atherosclerosis; 2012 Apr; 221(2):366-74. PubMed ID: 22281299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.
    Wuest TR; Carr DJ
    J Exp Med; 2010 Jan; 207(1):101-15. PubMed ID: 20026662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIP1 mediates vascular endothelial cell growth factor receptor-3-dependent angiogenic and lymphangiogenic responses.
    Zhou HJ; Chen X; Huang Q; Liu R; Zhang H; Wang Y; Jin Y; Liang X; Lu L; Xu Z; Min W
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):603-15. PubMed ID: 24407031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
    Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
    J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1.
    Jha SK; Rauniyar K; Karpanen T; Leppänen VM; Brouillard P; Vikkula M; Alitalo K; Jeltsch M
    Sci Rep; 2017 Jul; 7(1):4916. PubMed ID: 28687807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of lymphangiogenesis of endothelial progenitor cells with VEGFR-3 siRNA delivered with PEI-alginate nanoparticles.
    Li T; Wang GD; Tan YZ; Wang HJ
    Int J Biol Sci; 2014; 10(2):160-70. PubMed ID: 24520214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-455-3p regulates lymphangiogenesis in silicosis by regulating VEGF-C/VEGFR3.
    He H; Wang J; Zhang Y; Wang Y; Liu Y; Li X; Zhang Y; Yang J; Hao X; Wang H; Liu H
    Ecotoxicol Environ Saf; 2024 Jun; 278():116444. PubMed ID: 38728943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H-, N- and Kras cooperatively regulate lymphatic vessel growth by modulating VEGFR3 expression in lymphatic endothelial cells in mice.
    Ichise T; Yoshida N; Ichise H
    Development; 2010 Mar; 137(6):1003-13. PubMed ID: 20179099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DeepCAGE transcriptomics identify HOXD10 as a transcription factor regulating lymphatic endothelial responses to VEGF-C.
    Klein S; Dieterich LC; Mathelier A; Chong C; Sliwa-Primorac A; Hong YK; Shin JW; Lizio M; Itoh M; Kawaji H; Lassmann T; Daub CO; Arner E; ; Carninci P; Hayashizaki Y; Forrest AR; Wasserman WW; Detmar M
    J Cell Sci; 2016 Jul; 129(13):2573-85. PubMed ID: 27199372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
    Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
    Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.